Eagle Global Advisors LLC Gilead Sciences, Inc. Transaction History

Eagle Global Advisors LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2018 Aug 01, 2018	SELL	$64.88 - $75.68 $4.08 Million - $4.76 Million	-62,854 Closed	0 $0
Q1 2018 May 04, 2018	SELL	$72.84 - $88.8 $2,403 - $2,930	-33 Reduced 0.05%	62,854 $4.74 Million
Q4 2017 Feb 13, 2018	BUY	$71.15 - $83.52 $28,602 - $33,575	402 Added 0.64%	62,887 $4.51 Million
Q3 2017 Nov 13, 2017	BUY	$72.11 - $85.47 $4.51 Million - $5.34 Million	62,485	62,485 $5.06 Million

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Eagle Global Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Eagle Global Advisors LLC with notifications on news.